A panel of state experts would be authorized to determine the potency of a marijuana extract used to treat medical patients and which types of patients should be provided the drug, under a bill approved Tuesday by the Iowa Senate Judiciary Committee.
Senate Study Bill 3106 was sent to the Iowa Senate floor. It would grant the Medical Cannabidiol Board the authority to alter the definition of medical cannabidiol and to alter the list of debilitating medical conditions for which the use of medical cannabidiol would be medically beneficial.
Cannabidiol that is one of the main constituents of cannabis and has mild psychoactive effects.
“What we are trying to do is to empower professionals, and not state legislators, to make the decisions,” said Sen. Brad Zaun, R-Urbandale, a supporter of the bill.
Top photo courtesy of Adobe Stock
Source: Cannabis Business Times